Oxford Biomedical Research Centre is set to initiate a study into a new at-home test for diagnosing type 1 diabetes (T1D) in ...
The University of Glasgow has launched an innovative and exciting new postgraduate study programme with Indian biopharmaceutical giant Biocon.
1d
Stockhead on MSNDr Boreham’s Crucible: What’s all the fuss about biotech behemoth CSL?While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...
LoQus23 Therapeutics Ltd (“LoQus23”), a private biotechnology company investigating small molecule drugs that could stop the pathogenic triplet expansion that is the cause and driver of Huntington’s ...
Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, announces the ...
A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
Seasoned MedTech, Biotech and Digital Health leader and entrepreneur brings business and operational insights to fast-growing digital diagnostics company OXFORD, England, Feb. 18, 2025 ...
Chancellor Rachel Reeves is hoping the sun will shine on a 66-mile strip between Britain's top two universities which she ...
4d
News Medical on MSNPsychedelic treatments show promise for treating PTSD and depressionThe Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.
Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results